Ureteropelvic Junction Obstruction
15
5
5
5
Key Insights
Highlights
Success Rate
71% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
13.3%
2 terminated out of 15 trials
71.4%
-15.1% vs benchmark
13%
2 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 5 completed trials
Clinical Trials (15)
Renal SWE as a Predictor After Pediatric Pyeloplasty for UPJO
Ketamine Added to Quadratus Lumborum Block for Pain Relief After Infant Pyeloplasty
Diagnostic Relevance of Laser Confocal Microscopy for the Screening of Upper Urinary Tract Tumors
Ultrasound Localization Microscopy in Patient With Congenital Anomalies of the Kidney and Urinary Tract (CAKUT)
Comparison Between Classic Laparoscopic Dismembered Pyeloplasty and Insitu Spatulation with Pre-Dismembering Ureteropelvic Angle Suturing.
Pediatric Robotic Versus Open Pyeloplasty
Decision Aid for Parents of Infants With UPJO
The PRO-FUTURE Project
Long-term Outcome of Retroperitoneoscopic One-trocar-assisted Pyeloplasty: A Single-center and Single-surgeon Experience
The Efficacy and Safety of Chinese Domestic Surgical Robot System in Urological Telesurgery
Functional Outcome After Minimally Invasive Pyeloplasty for Adult Patients With UPJO
CTT on Renogram as an Early Marker of Significant Obstruction in Uretero-pelvic Junction Syndrome
The Correlation Between Renal Injury and Biomarkers in Pediatric Ureteropelvic Junction Obstruction Patients
Randomized Trial of NSAID vs Placebo Prior to Ureteral Stent Removal
Indwelling Double-J Ureteral Stent Versus Externalized Modified-Salle Stent for Pyeloplasty